Patents by Inventor Rosa PÉREZ PALACIOS

Rosa PÉREZ PALACIOS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PROTEIN SIGNATURE FOR SCREENING GENERAL POPULATION FOR COLORECTAL CANCER AND/OR PRE-CANCEROUS STAGE THEREOF
    Publication number: 20230204584
    Abstract: The present invention refers to an in vitro method for the diagnosis of colorectal cancer and/or pre-cancerous stage thereof.
    Type: Application
    Filed: March 18, 2021
    Publication date: June 29, 2023
    Inventors: Ana Carmen Martín Rodríguez, Lourdes Castillo García, Carmen Monsalve Hernando, Rosa Pérez Palacios, Rocío Arroyo Arranz
  • PROTEIN SIGNATURE FOR THE DIAGNOSIS OF COLORECTAL CANCER AND/OR PRE-CANCEROUS STAGE THEREOF
    Publication number: 20220276249
    Abstract: The present invention refers to an in vitro method for the diagnosis of colorectal cancer and/or pre-cancerous stage thereof.
    Type: Application
    Filed: February 28, 2020
    Publication date: September 1, 2022
    Inventors: Ana Carmen Martín Rodríguez, Rosa Pérez Palacios, Rocío Arroyo Arranz
  • IN VITRO METHOD FOR IDENTIFYING COLORECTAL ADENOMAS OR COLORECTAL CANCER
    Publication number: 20220220562
    Abstract: The present invention refers to an in vitro method for identifying patients at risk of suffering from colorectal cancer and/or colorectal adenomas, preferably advanced colorectal adenomas, based on measuring the expression profile or level of some miRNAs which are up-regulated or over-expressed in patients suffering from said diseases.
    Type: Application
    Filed: January 6, 2022
    Publication date: July 14, 2022
    Inventors: Marta HERREROS VILLANUEVA, Ana María Carmen MARTÍN RODRÍGUEZ, Rosa PÉREZ PALACIOS, Miguel Angel MARTÍNEZ GONZÁLEZ, Meritxell GIRONELLA COS, Antoni CASTELLS GARANGOU, Rocío ARROYO ARRANZ
  • IN VITRO METHOD FOR IDENTIFYING COLORECTAL ADENOMAS OR COLORECTAL CANCER
    Publication number: 20190316212
    Abstract: The present invention refers to an in vitro method for identifying patients at risk of suffering from colorectal cancer and/or colorectal adenomas, preferably advanced colorectal adenomas, based on measuring the expression profile or level of some miRNAs, e.g. miR-15b, which are up-regulated or over-expressed in patients suffering from said diseases.
    Type: Application
    Filed: November 27, 2017
    Publication date: October 17, 2019
    Inventors: Marta HERREROS VILLANUEVA, Ana María Carmen MARTN RODRÍGUEZ, Rosa PÉREZ PALACIOS, Miguel Angel MARTÍNEZ GONZÁLEZ, Meritxell GIRONELLA COS, Antoni CASTELLS GARANGOU, Rocío ARROYO ARRANZ